Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 5,032	$ 4,828
Accounts receivable	4,830	5,032
Other current assets	1,576	2,294
Total current assets	11,438	12,154
Property and equipment, net	762	480
Intangible assets, net	27	861
Operating lease right of use assets	1,978	2,439
Other long-term assets	45	45
Total assets	14,250	15,979
Current liabilities:
Accounts payable	1,352	1,050
Accrued salary and bonus	1,299	1,456
Other accrued expenses	8,815	8,419
Line of credit - current		2,500
Current liabilities of discontinued operations	858	858
Total current liabilities	12,324	14,283
Contingent consideration		518
Operating lease liabilities, net of current portion	1,556	1,848
Note payable at fair value	11,565	11,165
Other long-term liabilities	4,949	4,701
Total liabilities	30,394	32,515
Commitments and contingencies (Note 9)
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 shares Series B issued and outstanding	46,536	46,536
Stockholders’ deficit:
Common stock, $.01 par value; 100,000,000 shares authorized; 4,407,492 and 4,367,830 shares issued, respectively; 4,321,772 and 4,296,710 shares outstanding, respectively	405	405
Additional paid-in capital	188,017	187,516
Accumulated deficit	(249,105)	(249,017)
Treasury stock, at cost (85,720 and 71,120 shares, respectively)	(1,997)	(1,976)
Total stockholders’ deficit	(62,680)	(63,072)
Total liabilities and stockholders’ deficit	(32,286)	(30,557)
Total liabilities, preferred stock and stockholders’ deficit	$ 14,250	$ 15,979